An orally effective iron chelating drug for use in the treatment of chronic iron overload is badly needed. the principle aim of this phase i proposal is to develop a cost effective synthesis of n,n'-bis(o-hydroxybenzyl) ethylenediamine-n,n'-diacetic acid (hbed), an iron chelatingagent which has…
More